Filing Flows › Solesence (SLSN) › R&D spending
Solesence (SLSN) R&D spending by quarter
Solesence's R&D spending was $947K in Q2 2026 (second quarter 2026), -9% from Q1 2026. Over the last 7 quarters it ranged from $947K (Q2 2026) to $1.1M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $947K | -9% | -0.8% |
| Q1 2026 | $1.0M | +0.7% | +2% |
| Q4 2025 | $1.0M | -4% | -5% |
| Q3 2025 | $1.1M | +13% | — |
| Q2 2025 | $955K | -6% | — |
| Q1 2025 | $1.0M | -7% | — |
| Q4 2024 | $1.1M | — | — |
Q2 2026 at a glance
Solesence, Q2 2026: revenue $15.3M (-25% year over year), operating margin 0.8%, net loss $158K, operating cash flow $191K. The chart follows the revenue to costs, profit and cash.
Questions
What is Solesence's R&D spending?
Solesence's R&D spending was $947K in Q2 2026 (second quarter 2026), -9% from Q1 2026.
How has Solesence's R&D spending changed?
Over the last 7 quarters it ranged from $947K (Q2 2026) to $1.1M (Q4 2024).